Diagnosis and management of metabolic dysfunction-associated steatohepatitis in patients with chronic hepatitis B infection - PubMed
14 hours ago
- #Chronic Hepatitis B
- #Liver Disease
- #Metabolic Syndrome
- Chronic hepatitis B (CHB) affects over 250 million people globally and leads to serious liver conditions.
- Metabolic dysfunction-associated steatotic liver disease (MASLD) co-occurs in 25%-40% of CHB patients.
- Co-existing CHB and metabolic syndrome (Met-HBV) may worsen antiviral response and clinical outcomes.
- The review discusses diagnosis, risk stratification, and management strategies for Met-HBV.
- Recent data highlight the need for better understanding of Met-HBV's physiological and clinical impacts.